These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 18477733

  • 1. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR, Dhakal-Karki S, Dunican KC.
    Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
    [Abstract] [Full Text] [Related]

  • 2. Pharmacotherapeutic options for overweight adolescents.
    Dunican KC, Desilets AR, Montalbano JK.
    Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metformin and body weight.
    Golay A.
    Int J Obes (Lond); 2008 Jan; 32(1):61-72. PubMed ID: 17653063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of metformin in the treatment of gestational diabetes.
    Wensel TM.
    Ann Pharmacother; 2009 May; 43(5):939-43. PubMed ID: 19401478
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS, Kazemi F, Najafian A, Mohammady M, Aminorroaya A, Amini M.
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [Abstract] [Full Text] [Related]

  • 12. Acarbose for polycystic ovary syndrome.
    Kircher C, Smith KP.
    Ann Pharmacother; 2008 Jun; 42(6):847-51. PubMed ID: 18460589
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metformin: diamonds are forever.
    Papanas N, Maltezos E, Mikhailidis DP.
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [Abstract] [Full Text] [Related]

  • 16. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M, Aronne LJ.
    Am J Cardiol; 2007 Feb 19; 99(4A):68B-79B. PubMed ID: 17307059
    [Abstract] [Full Text] [Related]

  • 17. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
    Andreadis EA, Katsanou PM, Georgiopoulos DX, Tsourous GI, Yfanti GK, Gouveri ET, Diamantopoulos EJ.
    Exp Clin Endocrinol Diabetes; 2009 Apr 19; 117(4):175-80. PubMed ID: 19053032
    [Abstract] [Full Text] [Related]

  • 18. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U, Pop-Busui R, Eagle KA.
    Ann Pharmacother; 2008 Oct 19; 42(10):1466-74. PubMed ID: 18698014
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 19; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.